479 related articles for article (PubMed ID: 25418617)
1. microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro.
Xing Y; Hou J; Guo T; Zheng S; Zhou C; Huang H; Chen Y; Sun K; Zhong T; Wang J; Li H; Wang T
Stem Cell Res Ther; 2014 Nov; 5(6):130. PubMed ID: 25418617
[TBL] [Abstract][Full Text] [Related]
2. Apelin promotes mesenchymal stem cells survival and vascularization under hypoxic-ischemic condition in vitro involving the upregulation of vascular endothelial growth factor.
Hou J; Zhong T; Guo T; Miao C; Zhou C; Long H; Wu H; Zheng S; Wang L; Wang T
Exp Mol Pathol; 2017 Apr; 102(2):203-209. PubMed ID: 28161441
[TBL] [Abstract][Full Text] [Related]
3. microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.
Zhang Y; Lei W; Yan W; Li X; Wang X; Zhao Z; Hui J; Shen Z; Yang J
Stem Cell Res Ther; 2016 Apr; 7(1):61. PubMed ID: 27103465
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-486 regulates angiogenic activity and survival of mesenchymal stem cells under hypoxia through modulating Akt signal.
Shi XF; Wang H; Xiao FJ; Yin Y; Xu QQ; Ge RL; Wang LS
Biochem Biophys Res Commun; 2016 Feb; 470(3):670-677. PubMed ID: 26801559
[TBL] [Abstract][Full Text] [Related]
5. MiR-136 contributes to pre-eclampsia through its effects on apoptosis and angiogenesis of mesenchymal stem cells.
Ji L; Zhang L; Li Y; Guo L; Cao N; Bai Z; Song Y; Xu Z; Zhang J; Liu C; Ma X
Placenta; 2017 Feb; 50():102-109. PubMed ID: 28161054
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p.
Hou J; Wang L; Wu Q; Zheng G; Long H; Wu H; Zhou C; Guo T; Zhong T; Wang L; Chen X; Wang T
Stem Cell Res Ther; 2018 Apr; 9(1):109. PubMed ID: 29673400
[TBL] [Abstract][Full Text] [Related]
7. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kang D; Chang JW; Choi SW; Kang KS; Kim DI
Tissue Cell; 2017 Dec; 49(6):680-690. PubMed ID: 28958480
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of GFP-Bcl-2-engineered mesenchymal stem cells towards a nucleus pulposus-like phenotype under hypoxia in vitro.
Fang Z; Yang Q; Luo W; Li GH; Xiao J; Li F; Xiong W
Biochem Biophys Res Commun; 2013 Mar; 432(3):444-50. PubMed ID: 23416353
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF.
Liu L; Gao J; Yuan Y; Chang Q; Liao Y; Lu F
Cell Biol Int; 2013 Jun; 37(6):551-60. PubMed ID: 23505143
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral vector-mediated co-overexpression of VEGF and Bcl-2 improves mesenchymal stem cell survival and enhances paracrine effects in vitro.
Ni X; Ou C; Guo J; Liu B; Zhang J; Wu Z; Li H; Chen M
Int J Mol Med; 2017 Aug; 40(2):418-426. PubMed ID: 28627637
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro.
Bader AM; Klose K; Bieback K; Korinth D; Schneider M; Seifert M; Choi YH; Kurtz A; Falk V; Stamm C
PLoS One; 2015; 10(9):e0138477. PubMed ID: 26380983
[TBL] [Abstract][Full Text] [Related]
15. Hypoxic preconditioning potentiates the trophic effects of mesenchymal stem cells on co-cultured human primary hepatocytes.
Qin HH; Filippi C; Sun S; Lehec S; Dhawan A; Hughes RD
Stem Cell Res Ther; 2015 Dec; 6():237. PubMed ID: 26626568
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-Induced Mesenchymal Stromal Cells Exhibit an Enhanced Therapeutic Effect on Radiation-Induced Lung Injury in Mice due to an Increased Proliferation Potential and Enhanced Antioxidant Ability.
Li B; Li C; Zhu M; Zhang Y; Du J; Xu Y; Liu B; Gao F; Liu H; Cai J; Yang Y
Cell Physiol Biochem; 2017; 44(4):1295-1310. PubMed ID: 29183009
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126.
Liu W; Li L; Rong Y; Qian D; Chen J; Zhou Z; Luo Y; Jiang D; Cheng L; Zhao S; Kong F; Wang J; Zhou Z; Xu T; Gong F; Huang Y; Gu C; Zhao X; Bai J; Wang F; Zhao W; Zhang L; Li X; Yin G; Fan J; Cai W
Acta Biomater; 2020 Feb; 103():196-212. PubMed ID: 31857259
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
Hu X; Yu SP; Fraser JL; Lu Z; Ogle ME; Wang JA; Wei L
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
